INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
CP

Carey Stephen P.

SVP & CFOCIK 0001674236

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 3
Max Insider Score14
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CP
Carey Stephen P.SVP & CFO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$208K
2,850 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ANI PHARMACEUTICALS INCSVP & CFO · Jun 30, 2026
14
CP
Carey Stephen P.SVP & CFO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL
$208K
2,850 sh
Sep 29, 2026
Sep 30, 2026
traded Sep 29, 2026
+1d
SEC FORM 4

Evidence

8
CP
Carey Stephen P.SVP & CFO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$240K
2,850 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence